Literature DB >> 19587137

Enhanced T- and B-cell responses to simian immunodeficiency virus (SIV)agm, SIVmac and human immunodeficiency virus type 1 Gag DNA immunization and identification of novel T-cell epitopes in mice via codon optimization.

Christine S Siegismund1, Oliver Hohn1, Reinhard Kurth1, Stephen Norley1.   

Abstract

As a prelude to primate studies, the immunogenicity of wild-type and codon-optimized versions of simian immunodeficiency virus (SIV)agm Gag DNA, with and without co-administered granulocyte-macrophage colony-stimulating factor (GM-CSF) DNA, was directly compared in two strains of mice. Gag-specific T cells in the splenocytes of BALB/c and C57BL/6 mice immunized by gene gun were quantified by ELISpot using panels of overlapping synthetic peptides (15mers) spanning the entire capsid proteins of SIVagm, SIVmac and human immunodeficiency virus type 1. Specific antibodies were measured by ELISA. Codon optimization was shown to significantly increase the immune response to the DNA immunogens, reducing the amount of DNA necessary to induce cellular and antibody responses by one and two orders of magnitude, respectively. Co-administration of murine GM-CSF DNA was necessary for the induction of high level T- and B-cell responses. Finally, it was possible to identify both known and novel T-cell epitopes in the Gag proteins of the three viruses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19587137     DOI: 10.1099/vir.0.013730-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Schistosoma mansoni soluble egg antigens enhance T cell responses to a newly identified HIV-1 Gag H-2b epitope.

Authors:  Cac T Bui; Lisa M Shollenberger; Yvonne Paterson; Donald A Harn
Journal:  Clin Vaccine Immunol       Date:  2014-12-17

Review 2.  The future of human DNA vaccines.

Authors:  Lei Li; Fadi Saade; Nikolai Petrovsky
Journal:  J Biotechnol       Date:  2012-09-07       Impact factor: 3.307

Review 3.  Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.

Authors:  Seleeke Flingai; Matias Czerwonko; Jonathan Goodman; Sagar B Kudchodkar; Kar Muthumani; David B Weiner
Journal:  Front Immunol       Date:  2013-11-04       Impact factor: 7.561

4.  Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma.

Authors:  Alessandra Lopes; Kevin Vanvarenberg; Véronique Préat; Gaëlle Vandermeulen
Journal:  Mol Ther Nucleic Acids       Date:  2017-07-13       Impact factor: 8.886

5.  Codon optimization of antigen coding sequences improves the immune potential of DNA vaccines against avian influenza virus H5N1 in mice and chickens.

Authors:  Anna Stachyra; Patrycja Redkiewicz; Piotr Kosson; Anna Protasiuk; Anna Góra-Sochacka; Grzegorz Kudla; Agnieszka Sirko
Journal:  Virol J       Date:  2016-08-26       Impact factor: 4.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.